Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BHVNBiohaven Ltd.

NYSE · CIK 0001935979
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts217

Identity from submissions API

NameBiohaven Ltd.
CIK0001935979
TickersBHVN
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationD8 Virgin Islands, British
Phone203-404-0410
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Biohaven Research Ltd. (2022-07-01T04:00:00.000Z → 2022-09-14T04:00:00.000Z)
Business address
215 CHURCH STREET
NEW HAVEN
CT
06510
CT
Mailing address
215 CHURCH STREET
NEW HAVEN
CT
06510
CT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

284 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000262 005-93806 261558436 34 12970
2026-11-16 8-K 8-K 7.01,9.01 0001935979-26-000096 001-41477 261555095 34 15314697 1 1
2026-10-29 8-K 8-K 2.02,9.01 0001935979-26-000093 001-41477 261501666 34 315259 1 1
2026-10-29 10-Q 10-Q 0001935979-26-000092 001-41477 261501617 34 19861561 1 1
2026-10-22 8-K 8-K 7.01,9.01 0001935979-26-000083 001-41477 261477175 34 138292 1 1
2026-10-15 8-K 8-K 1.01,7.01,9.01 0001935979-26-000080 001-41477 261463722 34 961132 1 1
2026-09-17 4 FORM 4 0001704186-26-000006 6188
2026-09-10 8-K 8-K 8.01 0001935979-26-000077 001-41477 261369524 34 140268 1 1
2026-08-26 8-K 8-K 1.01,7.01,9.01 0001935979-26-000072 001-41477 261317531 34 890201 1 1
2026-08-14 3 FORM 3 0002150506-26-000002 276920
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005259 005-93806 261277820 34 8778
2026-08-10 8-K 8-K 2.02,9.01 0001935979-26-000067 001-41477 261258779 34 300988 1 1
2026-08-10 10-Q 10-Q 0001935979-26-000066 001-41477 261258741 34 19247014 1 1
2026-08-07 8-K 8-K 5.02,9.01 0001935979-26-000060 001-41477 261254081 34 136951 1 1
2026-07-17 3 FORM 3 0002146037-26-000003 282647
2026-07-09 8-K 8-K 5.02,9.01 0001935979-26-000053 001-41477 261166364 34 154145 1 1
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000170 005-93806 261163382 34 12362
2026-05-27 8-K 8-K 7.01,9.01 0001935979-26-000048 001-41477 261027517 34 47276433 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000140 005-93806 26984903 34 12063
2026-05-05 8-K 8-K 8.01,9.01 0001628280-26-030579 001-41477 26943485 34 249039 1 1
2026-05-04 424B5 424B5 0001628280-26-029924 333-295531 26938948 33 767824 1 1
2026-05-04 S-3ASR S-3ASR 0001628280-26-029834 333-295531 26938015 33 807874 1 1
2026-05-04 10-Q 10-Q 0001935979-26-000045 001-41477 26937567 34 15280718 1 1
2026-05-04 8-K 8-K 2.02,9.01 0001935979-26-000044 001-41477 26937531 34 266936 1 1
2026-05-04 8-K 8-K 5.07 0001935979-26-000042 001-41477 26937347 34 145484 1 1
2026-04-30 4 FORM 4 0001850520-26-000005 5556
2026-04-30 4 FORM 4 0001329505-26-000005 5556
2026-04-30 4 FORM 4 0001448914-26-000002 5610
2026-04-30 4 FORM 4 0001926476-26-000002 5540
2026-04-30 4 FORM 4 0001027035-26-000008 5557
2026-04-30 4 FORM 4 0001232505-26-000003 5563
2026-04-30 4 FORM 4 0001226675-26-000002 5551
2026-03-19 4 FORM 4 0001850520-26-000003 6679
2026-03-13 DEFA14A DEFA14A 0001935979-26-000030 001-41477 26753274 34 1208180
2026-03-13 DEF 14A DEF 14A 0001935979-26-000028 001-41477 26753243 34 4951175 1 1
2026-03-09 4/A FORM 4/A 0001027035-26-000006 6845
2026-03-03 4 FORM 4 0001898799-26-000004 5400
2026-03-03 4 FORM 4 0001704186-26-000004 5461
2026-03-03 4 FORM 4 0001878290-26-000004 5388
2026-03-03 4 FORM 4 0001798876-26-000004 5420
2026-03-03 4 FORM 4 0001704317-26-000004 5448
2026-03-02 8-K 8-K 2.02,9.01 0001935979-26-000022 001-41477 26708293 34 340800 1 1
2026-03-02 S-8 S-8 0001935979-26-000021 333-293933 26708177 33 323579 1 1
2026-03-02 10-K 10-K 0001935979-26-000020 001-41477 26707637 34 49949075 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-000942 005-93806 26633399 34 16877
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000045 005-93806 26608164 34 11981
2026-01-12 8-K 8-K 7.01,9.01 0001935979-26-000005 001-41477 26525415 34 14949924 1 1
2026-01-07 4 FORM 4 0001704186-26-000002 8703
2026-01-07 4 FORM 4 0001898799-26-000002 8883
2026-01-07 4 FORM 4 0001704317-26-000002 11461
2026-01-07 4 FORM 4 0001798876-26-000002 9584
2026-01-07 4 FORM 4 0001878290-26-000002 9316
2026-01-07 8-K 8-K 8.01 0001935979-26-000002 001-41477 26513683 34 131915 1 1
2025-11-18 4 FORM 4 0001878290-25-000004 5962
2025-11-17 4 FORM 4 0001935979-25-000096 4625
2025-11-17 4 FORM 4 0001027035-25-000004 7627
2025-11-17 4 FORM 4 0001704317-25-000004 8514
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000271 005-93806 251482360 34 9373
2025-11-13 8-K 8-K 8.01,9.01 0001628280-25-052066 001-41477 251478995 34 567625 1 1
2025-11-13 424B5 424B5 0001628280-25-051841 333-274822 251475367 33 798718 1 1
2025-11-12 424B5 424B5 0001628280-25-051257 333-274822 251468154 33 646627
2025-11-10 10-Q 10-Q 0001935979-25-000092 001-41477 251464472 34 16433400 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001935979-25-000090 001-41477 251464273 34 284098 1 1
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000041 005-93806 251434246 34 6244
2025-08-22 8-K 8-K 7.01 0001935979-25-000080 001-41477 251242175 34 133681 1 1
2025-08-15 8-K 8-K 8.01,9.01 0001935979-25-000074 001-41477 251225694 34 292410 1 1
2025-08-15 424B7 424B7 0001935979-25-000073 333-274822 251225691 33 587023 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000199 005-93806 251215463 34 9494
2025-08-11 10-Q 10-Q 0001935979-25-000068 001-41477 251202282 34 21689512 1 1
2025-08-11 8-K 8-K 2.02,9.01 0001935979-25-000067 001-41477 251202001 34 303977 1 1
2025-06-04 8-K 8-K 7.01,9.01 0001935979-25-000058 001-41477 251022013 34 27100989 1 1
2025-05-15 8-K 8-K 7.01,9.01 0001935979-25-000056 001-41477 25948254 34 165953 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000155 005-93806 25943950 34 9493
2025-05-12 10-Q 10-Q 0001935979-25-000054 001-41477 25935120 34 22722246 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001935979-25-000053 001-41477 25934829 34 289122 1 1
2025-05-07 8-K 8-K 5.07 0001935979-25-000049 001-41477 25922757 34 152666 1 1
2025-05-07 4 FORM 4 0001935979-25-000048 5401
2025-05-07 4 FORM 4 0001935979-25-000046 5476
2025-05-07 4 FORM 4 0001935979-25-000045 5395
2025-05-07 4 FORM 4 0001935979-25-000044 5417
2025-05-07 4 FORM 4 0001935979-25-000043 5412
2025-05-07 4 FORM 4 0001935979-25-000042 5418
2025-05-07 4 FORM 4 0001935979-25-000041 5424
2025-04-28 8-K 8-K 1.01,2.03,7.01,9.01 0001935979-25-000026 001-41477 25875978 34 1389785 1 1
2025-03-18 DEFA14A DEFA14A 0001935979-25-000023 001-41477 25749158 34 1192141
2025-03-18 DEF 14A DEF 14A 0001935979-25-000022 001-41477 25749131 34 4092656 1 1
2025-03-05 4 FORM 4 0001935979-25-000018 11055
2025-03-05 4/A FORM 4/A 0001935979-25-000017 6331
2025-03-03 8-K 8-K 2.02,9.01 0001935979-25-000016 001-41477 25698383 34 356632 1 1
2025-03-03 10-K 10-K 0001935979-25-000015 001-41477 25698360 34 48638616 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000076 005-93806 25625647 34 9507
2025-01-13 8-K 8-K 7.01,9.01 0001935979-25-000008 001-41477 25525388 34 9708072 1 1
2025-01-07 4 FORM 4 0001935979-25-000006 13663
2025-01-07 4 FORM 4 0001935979-25-000005 13006
2025-01-07 4 FORM 4 0001935979-25-000004 14000
2025-01-07 4 FORM 4 0001935979-25-000003 13332
2025-01-07 4 FORM 4 0001935979-25-000002 15766
2024-12-31 4 FORM 4 0001935979-24-000088 7322
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000132 005-93806 241460766 34 10525
2024-11-12 8-K 8-K 2.02,9.01 0001935979-24-000086 001-41477 241448424 34 307965 1 1
2024-11-12 10-Q 10-Q 0001935979-24-000085 001-41477 241448249 34 21961346 1 1
2024-11-12 SC 13G/A UnitedStates_13G__BiohavenLt.txt 0000932471-24-000826 005-93806 241446426 34 6571
2024-11-04 SC 13G/A UnitedStates_13G__BiohavenLt.txt 0000932471-24-000285 005-93806 241421427 34 5654
2024-10-22 CT ORDER filename1.pdf 20241022,20241022 9999999997-24-004159 001-41477 241386360 34 121417
2024-10-03 4 FORM 4 0001935979-24-000078 6921
2024-10-03 4 FORM 4 0001935979-24-000077 7682
2024-10-02 8-K 8-K 8.01,9.01 0001628280-24-041894 001-41477 241347595 34 523156 1 1
2024-10-01 424B5 424B5 0001628280-24-041729 333-274822 241343279 33 802731 1 1
2024-09-30 424B5 424B5 0001628280-24-041609 333-274822 241340569 33 640967
2024-09-25 4 FORM 4 0001935979-24-000075 5005
2024-09-23 8-K 8-K 7.01,8.01,9.01 0001935979-24-000073 001-41477 241314820 34 4764329 1 1
2024-08-16 8-K 8-K 8.01,9.01 0001628280-24-037576 001-41477 241217182 34 286666 1 1
2024-08-16 424B7 424B7 0001628280-24-037575 333-274822 241217138 33 598246 1 1
2024-08-16 8-K 8-K 8.01,9.01 0001628280-24-037568 001-41477 241217018 34 271355 1 1
2024-08-16 424B5 424B5 0001628280-24-037565 333-274822 241216986 33 755215 1 1
2024-08-09 10-Q 10-Q 0001935979-24-000069 001-41477 241192752 34 20503541 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001935979-24-000063 001-41477 241188666 34 322224 1 1
2024-07-19 4 PRIMARY DOCUMENT 0001562180-24-005805 6850
2024-06-20 4 PRIMARY DOCUMENT 0001562180-24-005174 5773
2024-05-31 4 PRIMARY DOCUMENT 0001562180-24-004529 6847
2024-05-17 8-K 8-K 8.01,9.01 0001935979-24-000053 001-41477 24960577 34 286072 1 1
2024-05-17 424B7 424B7 0001935979-24-000052 333-274822 24960546 33 482545
2024-05-15 4 PRIMARY DOCUMENT 0001562180-24-004045 8509
2024-05-14 4 PRIMARY DOCUMENT 0001562180-24-004011 6848
2024-05-09 S-8 S-8 0001935979-24-000048 333-279258 24930923 33 265103
2024-05-09 8-K 8-K 2.02,9.01 0001935979-24-000047 001-41477 24930805 34 288917 1 1
2024-05-09 10-Q 10-Q 0001935979-24-000046 001-41477 24930668 34 14350766 1 1
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003755 5665
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003754 5724
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003753 5660
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003752 5672
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003751 5649
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003750 5666
2024-05-02 4 PRIMARY DOCUMENT 0001562180-24-003749 5643
2024-05-01 8-K 8-K 5.07 0001935979-24-000035 001-41477 24904189 34 155832 1 1
2024-04-25 4 PRIMARY DOCUMENT 0001562180-24-003521 5243
2024-04-23 4 PRIMARY DOCUMENT 0001562180-24-003495 4842
2024-04-23 4 PRIMARY DOCUMENT 0001562180-24-003494 8369
2024-04-23 4 PRIMARY DOCUMENT 0001562180-24-003493 7683
2024-04-22 8-K 8-K 8.01,9.01 0001628280-24-017139 001-41477 24861546 34 562632 1 1
2024-04-19 424B5 424B5 0001628280-24-016854 333-274822 24855520 33 688486
2024-04-17 424B5 424B5 0001628280-24-016576 333-274822 24850941 33 658749
2024-04-15 8-K 8-K 7.01,9.01 0001935979-24-000031 001-41477 24843077 34 2451330 1 1
2024-04-05 4 PRIMARY DOCUMENT 0001562180-24-003337 5649
2024-04-05 4 PRIMARY DOCUMENT 0001562180-24-003336 10228
2024-03-18 DEFA14A DEFA14A 0001935979-24-000028 001-41477 24759368 34 1220220
2024-03-18 DEF 14A DEF 14A 0001935979-24-000026 001-41477 24759299 34 3716696 1 1
2024-03-12 8-K 8-K 8.01,9.01 0001935979-24-000020 001-41477 24742821 34 284107 1 1
2024-03-12 424B7 424B7 0001935979-24-000018 333-274822 24742748 33 482369
2024-03-08 4 PRIMARY DOCUMENT 0001562180-24-002510 6063
2024-03-08 4 PRIMARY DOCUMENT 0001562180-24-002509 10232
2024-02-29 8-K 8-K 2.02,9.01 0001935979-24-000011 001-41477 24703883 34 345943 1 1
2024-02-29 10-K 10-K 0001935979-24-000010 001-41477 24703814 34 40954444 1 1
2024-02-14 SC 13G/A BIOHAVEN LTD. 0000902664-24-001532 005-93806 24632169 34 75651
2024-02-13 SC 13G/A d10964661_13g-a.htm 0000919574-24-001063 005-93806 24628927 34 107161
2024-02-13 SC 13G/A JHG PLC OWNS >5% 0001274173-24-000028 005-93806 24624059 34 10530
2024-02-06 SC 13G vgg1110e1079_020524.txt 0001086364-24-006595 005-93806 24598402 34 13652
2024-01-23 SC 13G/A Biohaven_Ltd.txt 0000093751-24-000101 005-93806 24550928 34 8464
2024-01-10 4 PRIMARY DOCUMENT 0001562180-24-000427 5960
2024-01-10 4 PRIMARY DOCUMENT 0001562180-24-000426 9823
2024-01-08 8-K 8-K 7.01,9.01 0001935979-24-000002 001-41477 24518340 34 9931020 1 1
2024-01-04 4 PRIMARY DOCUMENT 0001562180-24-000287 5607
2024-01-04 4 PRIMARY DOCUMENT 0001562180-24-000286 5632
2024-01-04 4 PRIMARY DOCUMENT 0001562180-24-000285 5660
2024-01-04 4 PRIMARY DOCUMENT 0001562180-24-000284 5599
2024-01-04 4 PRIMARY DOCUMENT 0001562180-24-000283 5649
2023-12-29 4 PRIMARY DOCUMENT 0001562180-23-008590 9110
2023-12-29 144 xsl144X01/primary_doc.xml 0001972362-23-001235 001-41477 231527569 33 4212
2023-11-14 8-K 8-K 2.02,9.01 0001935979-23-000064 001-41477 231406851 34 330762 1 1
2023-11-14 10-Q 10-Q 0001935979-23-000062 001-41477 231406435 34 14889079 1 1
2023-11-06 4 PRIMARY DOCUMENT 0001562180-23-007580 5520
2023-11-06 4 PRIMARY DOCUMENT 0001562180-23-007579 5570
2023-11-06 4 PRIMARY DOCUMENT 0001562180-23-007578 5528
2023-11-06 4 PRIMARY DOCUMENT 0001562180-23-007577 5581
2023-11-06 4 PRIMARY DOCUMENT 0001562180-23-007576 8771
2023-10-18 SC 13G BIOHAVEN LTD. 0000902664-23-005144 005-93806 231332419 34 84747
2023-10-10 4 PRIMARY DOCUMENT 0001562180-23-007253 6614
2023-10-10 4 PRIMARY DOCUMENT 0001562180-23-007246 8567
2023-10-06 4 PRIMARY DOCUMENT 0001562180-23-007229 4781
2023-10-06 4 PRIMARY DOCUMENT 0001562180-23-007228 5162
2023-10-05 8-K 8-K 8.01,9.01 0001628280-23-033962 001-41477 231311368 34 624933 1 1
2023-10-04 424B5 424B5 0001628280-23-033814 333-274822 231307935 33 684324
2023-10-03 8-K 8-K 8.01,9.01 0001628280-23-033545 001-41477 231301470 34 637232 1 1
2023-10-02 424B5 424B5 0001628280-23-033510 333-274822 231300587 33 653526
2023-10-02 424B5 424B5 0001628280-23-033506 333-274822 231300571 33 578490
2023-10-02 S-3ASR S-3ASR 0001628280-23-033472 333-274822 231299557 33 1193411
2023-09-27 8-K 8-K 7.01,9.01 0001935979-23-000054 001-41477 231281790 34 13781549 1 1
2023-08-31 4 PRIMARY DOCUMENT 0001562180-23-006632 5499
2023-08-07 4 PRIMARY DOCUMENT 0001562180-23-006204 5500
2023-07-31 10-Q 10-Q 0001935979-23-000052 001-41477 231128453 34 9063881 1 1
2023-07-31 8-K 8-K 2.02,9.01 0001935979-23-000049 001-41477 231127727 34 322015 1 1
2023-07-28 8-K 8-K 7.01,9.01 0001935979-23-000046 001-41477 231123624 34 177862 1 1
2023-05-31 8-K 8-K 7.01,9.01 0001935979-23-000037 001-41477 23978908 34 203682 1 1
2023-05-12 8-K 8-K 2.02,9.01 0001935979-23-000033 001-41477 23916645 34 319514 1 1
2023-05-12 S-8 S-8 0001935979-23-000031 333-271886 23916569 33 264370
2023-05-12 10-Q 10-Q 0001935979-23-000029 001-41477 23916464 34 7906200 1 1
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003946 8825
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003945 8833
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003944 8829
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003943 8896
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003942 8838
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003941 8892
2023-05-04 4 PRIMARY DOCUMENT 0001562180-23-003940 8856
2023-05-04 8-K 8-K 5.02,5.07 0001935979-23-000019 001-41477 23889974 34 183194 1 1
2023-03-24 8-K 8-K 7.01,9.01 0001935979-23-000016 001-41477 23757355 34 8331422 1 1
2023-03-23 8-K 8-K 2.02,9.01 0001935979-23-000014 001-41477 23756741 34 365460 1 1
2023-03-23 DEFA14A DEFA14A 0001935979-23-000012 001-41477 23756645 34 1164685
2023-03-23 DEF 14A DEF 14A 0001935979-23-000011 001-41477 23756606 34 1429281
2023-03-23 10-K 10-K 0001935979-23-000009 001-41477 23756447 34 23585185 1 1
2023-03-22 4/A PRIMARY DOCUMENT 0001562180-23-003045 7903
2023-02-13 SC 13G/A d9927707_13g-a.htm 0000919574-23-001050 005-93806 23616650 34 119931
2023-02-13 SC 13G vgg1110e1079_021323.txt 0001306550-23-008640 005-93806 23616335 34 13131
2023-02-13 SC 13G/A JHG PLC OWNS >5% 0001274173-23-000069 005-93806 23615396 34 10442
2023-02-08 SC 13G Biohaven_Ltd.txt 0000093751-23-000347 005-93806 23597466 34 10260
2023-01-10 8-K 8-K 7.01,9.01 0001935979-23-000003 001-41477 23520005 34 4887056 1 1
2022-11-18 3 PRIMARY DOCUMENT 0001562180-22-007790 5683
2022-11-09 10-Q 10-Q 0001935979-22-000011 001-41477 221372917 34 6125576 1 1
2022-11-09 8-K 8-K 2.02,9.01 0001935979-22-000009 001-41477 221372507 34 332366 1 1
2022-11-02 SC 13G SCHEDULE 13G 0000899140-22-000766 005-93806 221352497 34 53630
2022-11-01 4 PRIMARY DOCUMENT 0001562180-22-007386 11197
2022-10-31 4 PRIMARY DOCUMENT 0001562180-22-007373 9440
2022-10-26 4 PRIMARY DOCUMENT 0001562180-22-007335 4726
2022-10-26 4 PRIMARY DOCUMENT 0001562180-22-007332 10153
2022-10-26 4 PRIMARY DOCUMENT 0001562180-22-007334 5467
2022-10-26 4 PRIMARY DOCUMENT 0001562180-22-007333 4746
2022-10-26 4 PRIMARY DOCUMENT 0001562180-22-007336 4739
2022-10-24 424B4 424B4 0001628280-22-026837 333-267928 221324971 33 5853832
2022-10-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-10-20 16:00:00 9999999995-22-003099 333-267928 221322121 33 1743
2022-10-20 S-1MEF S-1MEF 0001628280-22-026778 333-267965 221322092 33 225644
2022-10-20 S-1/A S-1/A 0001628280-22-026728 333-267928 221320199 33 5962321
2022-10-18 CORRESP filename1.htm 0001628280-22-026555 10853
2022-10-18 CORRESP filename1.htm 0001628280-22-026554 21431
2022-10-18 S-1 S-1 0001628280-22-026549 333-267928 221316040 33 6353093
2022-10-18 UPLOAD filename1.pdf 0000000000-22-011415 40391
2022-10-12 4/A PRIMARY DOCUMENT 0001562180-22-007176 6580
2022-10-12 4/A PRIMARY DOCUMENT 0001562180-22-007175 5534
2022-10-12 4/A PRIMARY DOCUMENT 0001562180-22-007174 5585
2022-10-11 DRS filename1.htm 0001628279-22-000416 377-06401 221304689 33 5848729
2022-10-11 S-8 S-8 0001628280-22-026247 333-267818 221304387 33 575043
2022-10-06 4 PRIMARY DOCUMENT 0001562180-22-007115 23251
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007104 7904
2022-10-05 4/A PRIMARY DOCUMENT 0001562180-22-007103 11701
2022-10-05 4/A PRIMARY DOCUMENT 0001562180-22-007102 7481
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007086 28268
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007085 86145
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007084 8322
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007083 5518
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007082 7480
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007081 35663
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007079 31648
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007078 21469
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007077 29741
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007076 23821
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007075 33446
2022-10-05 4 PRIMARY DOCUMENT 0001562180-22-007074 107227
2022-10-05 3 PRIMARY DOCUMENT 0001562180-22-007053 6437
2022-10-03 8-K 8-K 5.01,5.02,5.03,8.01,9.01 0001628280-22-025893 001-41477 221288633 34 344377
2022-09-30 3 FORM 3 0001628280-22-025806 7538
2022-09-30 3 FORM 3 0001628280-22-025805 7665
2022-09-30 3 FORM 3 0001628280-22-025804 7517
2022-09-30 3 FORM 3 0001628280-22-025803 7586
2022-09-30 3 FORM 3 0001628280-22-025802 7698
2022-09-30 3 FORM 3 0001628280-22-025801 7579
2022-09-30 3 FORM 3 0001628280-22-025799 7585
2022-09-30 3 FORM 3 0001628280-22-025798 7586
2022-09-28 3 FORM 3 0001628280-22-025656 7784
2022-09-28 3 FORM 3 0001628280-22-025655 7723
2022-09-28 3 FORM 3 0001628280-22-025654 4746
2022-09-28 8-K 8-K 7.01 0001628280-22-025588 001-41477 221272723 34 23944
2022-09-22 SEC STAFF ACTION filename1.pdf 9999999997-22-004235 15103
2022-09-20 CORRESP filename1.htm 0001628280-22-025210 11415
2022-09-20 CERT NYSE CERTIFICATION 0000876661-22-000769 001-41477 221253013 34 640849
2022-09-20 10-12B/A 10-12B/A 0001628280-22-025178 001-41477 221252058 34 5668788
2022-09-14 CORRESP filename1.htm 0001628280-22-024925 14505
2022-09-14 10-12B/A 10-12B/A 0001628280-22-024924 001-41477 221243787 34 5975613
2022-09-13 UPLOAD filename1.pdf 0000000000-22-009963 45888
2022-09-07 10-12B/A 10-12B/A 0001628280-22-024448 001-41477 221229926 34 6427172
2022-08-24 CORRESP filename1.htm 0001628280-22-023627 14147
2022-08-24 10-12B/A 10-12B/A 0001628280-22-023625 001-41477 221192201 34 5603012
2022-08-22 UPLOAD filename1.pdf 0000000000-22-009036 44194
2022-08-10 CORRESP filename1.htm 0001628280-22-022268 55419
2022-08-10 10-12B 10-12B 0001628280-22-022261 001-41477 221152649 34 10122851
2022-07-29 UPLOAD filename1.pdf 0000000000-22-007962 56759
2022-07-01 DRS filename1.htm 0001628279-22-000326 377-06259 221061993 33 7448254

Latest XBRL company facts

One latest value per concept from companyfacts (217 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 151.06M 2026-10-26 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
dei EntityPublicFloat Entity Public Float USD 1.04B 2025-06-30 2025 FY 10-K 2026-03-02 0001935979-26-000020
ffd NetFeeAmt NetFeeAmt USD 30,815.91 2026-05-04 424B5 2026-05-04 0001628280-26-029924
ffd TtlFeeAmt TtlFeeAmt USD 48,335 2026-05-04 424B5 2026-05-04 0001628280-26-029924
ffd TtlOfferingAmt TtlOfferingAmt USD 350.00M 2026-05-04 424B5 2026-05-04 0001628280-26-029924
ffd TtlOffsetAmt TtlOffsetAmt USD 17,519.09 2026-05-04 424B5 2026-05-04 0001628280-26-029924
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-04 424B5 2026-05-04 0001628280-26-029924
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 13.53M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 49.23M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 18.02M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 5.35M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 238.84M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 112.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.34M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 21.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap Assets Assets USD 263.68M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AssetsCurrent Assets, Current USD 191.51M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 135.69M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 25,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 65.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 65.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 65.37M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 65.37M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CapitalizedComputerSoftwareAccumulatedAmortization Capitalized Computer Software, Accumulated Amortization USD 654,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001935979-23-000062
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 760,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001935979-23-000062
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 95.75M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 38.97M 2024-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 98.66M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -134.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 151.06M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 151.06M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CommonStockValue Common Stock, Value, Issued USD 2.14B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -400.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CostsAndExpenses Costs and Expenses USD 381.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 1.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 264.29M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss USD 65.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 1,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions investment 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 65.37M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 25,000 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions investment 5 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DebtSecuritiesRealizedGainLoss Debt Securities, Realized Gain (Loss) USD -39,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001935979-23-000062
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 7.84M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.37M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 7.84M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 120.70M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 39.18M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 158.93M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses USD 3.44M 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.30M 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 313.35M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 7.84M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap Depreciation Depreciation USD 1.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 6.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 12.32M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001935979-24-000085
us-gaap DueToAffiliateCurrent Due to Affiliate, Current USD 0 2021-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.027 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.008 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.033 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 12.10M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 73.47M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap EquitySecuritiesFVNINoncurrent EquitySecuritiesFVNINoncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 264.29M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 75.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap Goodwill Goodwill USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -783.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -396.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 45.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001935979-24-000010
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 133,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 2.60M 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 599,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD -172,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD -97,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -59.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -18.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 18.40M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap InterestIncomeDebtSecuritiesOperating Interest Income, Debt Securities, Operating USD 3.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap InterestIncomeOther Interest Income, Other USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 216,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 7.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 72,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap InvestmentIncomeNet Investment Income, Net USD 7.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 89.18M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 63.08M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 23.09M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 9.14M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 7.15M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6.95M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 7.50M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 9.24M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 378,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001935979-22-000011
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 17.36M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap Liabilities Liabilities USD 361.92M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 263.68M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap LiabilitiesCurrent Liabilities, Current USD 62.77M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 264.29M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 65.37M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 183.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 24.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -341.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -397.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -14.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OperatingExpenses Operating Expenses USD 567.93M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -381.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OperatingLeaseCost Operating Lease, Cost USD 8.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 45.71M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.74M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 31.41M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OperatingLeasePayments Operating Lease, Payments USD 8.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 35.53M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.088 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 598.68M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001935979-23-000062
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 9.98M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.82M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherAssetsFairValueDisclosure Other Assets, Fair Value Disclosure USD 3.02M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 632,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001935979-22-000011
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 2.14M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 37.67M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Tax and Reclassification Adjustment, Attributable to Parent USD 8.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 8.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 8.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 114.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 634,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 27.57M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 178.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 4.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 140.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 219.14M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001935979-23-000062
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.57M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001935979-25-000092
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -570.28M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 14.70M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 306.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.13M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.48B 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 16.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 66.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.51M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 47.59M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 13.97M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 17.77 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 265,819 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 55.76M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 20.26M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 18.7 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 55.76M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 356.37M 2023-12-31 2023 FY 10-K 2024-02-29 0001935979-24-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 20.26M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 18.7 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 28.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 11.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -98.25M 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 538.77M 2022-12-31 2022 FY 10-K 2023-03-23 0001935979-23-000009
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.5 2022-10-03 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 721,136 2023-12-01 2023-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 343,814 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 188.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 10.81M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 451,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-03 0001935979-25-000015
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.60M 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001935979-26-000020
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 149.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 149.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-29 0001935979-26-000092

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →